Mirum Pharmaceuticals Appoints Eric Bjerkholt for the CFO position
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company committed to revolutionizing the treatment of rare diseases, has announced the appointment of Eric Bjerkholt as Chief Financial Officer. Chris Peetz, President and CEO of Mirum, expressed his confidence in Eric Bjerkholt's capabilities, emphasizing his impressive track record in financial performance, business...